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Known as a critical antioxidant, recent studies suggest that vitamin C plays an important
role in stem cell generation, proliferation and differentiation. Vitamin C also enhances
neural differentiation during cerebral development, a function that has not been studied in
brain precursor cells. We observed that the rat neurogenic niche is structurally organized
at day 15 of postnatal development, and proliferation and neural differentiation increase
at day 21. In the human brain, a similar subventricular niche was observed at 1-month of
postnatal development. Using immunohistochemistry, sodium-vitamin C cotransporter 2
(SVCT2) expression was detected in the subventricular zone (SVZ) and rostral migratory
stream (RMS). Low co-distribution of SVCT2 and βIII-tubulin in neuroblasts or type-A cells
was detected, and minimal co-localization of SVCT2 and GFAP in type-B or precursor
cells was observed. Similar results were obtained in the human neurogenic niche.
However, BrdU-positive cells also expressed SVCT2, suggesting a role of vitamin C in
neural progenitor proliferation. Primary neurospheres prepared from rat brain and the P19
teratocarcinoma cell line, which forms neurospheres in vitro, were used to analyze the
effect of vitamin C in neural stem cells. Both cell types expressed functional SVCT2 in vitro,
and ascorbic acid (AA) induced their neural differentiation, increased βIII-tubulin and SVCT2
expression, and amplified vitamin C uptake.
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INTRODUCTION
Active neurogenesis occurs within the anterior wall of the lateral
ventricle in the adult mammalian brain (Lois and Alvarez-Buylla,
1993; Doetsch et al., 1999). Neurogenic precursors have also been
found in the human brain, specifically located in the periven-
tricular region before 18 months of age (Johansson et al., 1999;
Nunes et al., 2003; Sanai et al., 2011; Bergmann et al., 2012).
The formation of new neurons, which are βIII-tubulin-positive,
occurs in restricted, organized compartments termed neurogenic
niches (Doetsch et al., 1997, 1999; Alvarez-Buylla and Garcia-
Verdugo, 2002; Conover and Notti, 2008; Mirzadeh et al., 2008;
Nualart et al., 2012). The neuroblasts formed in this region
migrate tangentially in chains throughout the rostral migratory
stream (RMS), where the presence of neurogenic progenitors and
astrocytes has also been described (Doetsch and Alvarez-Buylla,
1996). The neuroblasts present in the RMS reach the olfactory
bulb, where they differentiate into interneurons (Lois et al., 1996;
Alvarez-Buylla and Garcia-Verdugo, 2002; Lledo et al., 2008).
Ultrastructural, immunohistochemistry, and proliferation anal-
yses of the cytoarchitecture of the neurogenic niche (Doetsch
et al., 1997) have revealed the presence of four cell types. B-type
cells or astrocytes (GFAP- and nestin-positive) are preferentially
located in the subventricular zone (SVZ) and are precursor cells.
C-type cells are intermediate transient neuronal cells (nIPC)
that proliferate rapidly (Eisch and Mandyam, 2007; Ihrie and
Alvarez-Buylla, 2008) and differentiate into neuroblasts or type-A
cells (Doetsch et al., 1999; Tramontin et al., 2003; Chojnacki
et al., 2009; Kriegstein and Alvarez-Buylla, 2009; Nualart et al.,
2012). E-type cells, which are cube-shaped and multiciliated, are
ependymocytes. B-type cells are found in the ependymal layer,
projecting cilium to the ventricular lumen, similar to what has
been described in the radial glia (Tramontin et al., 2003; Spassky
et al., 2005); they also have a close relationship with blood ves-
sels (Mirzadeh et al., 2008). Precursor cells reactive to GFAP
have been identified in the SVZ of the human brain (Roy et al.,
2000; Gibbons and Dragunow, 2010), and some are in direct con-
tact with the cerebrospinal fluid (CSF) (Sanai et al., 2004, 2011;
Quinones-Hinojosa et al., 2006).
Vitamin C, which is present in high concentrations in the CSF
(Spector and Lorenzo, 1974; Kratzing et al., 1985), may be impor-
tant in postnatal neural differentiation. An important role for
vitamin C in embryonic cerebral development and in the differ-
entiation of dopaminergic and serotoninergic neurons has been
described (Lee et al., 2000; Yan et al., 2001). Embryonic precursors
supplemented with vitamin C show an increase in neural and glial
markers (Lee et al., 2003). Recently, Esteban et al. (2010) found
that vitamin C favored the generation of induced pluripotent stem
cells (iPS) (Esteban et al., 2010). Furthermore, cells grown in vitro
in the presence of vitamin C expressed two histone demethylases,
Jhdm1a and Jhdm1b (Wang et al., 2011), which are required for
iPS cell production. Together, these results suggest that vitamin C
is able to positively regulate stem cell generation and proliferation.
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The intracellular incorporation of ascorbic acid (AA) by neu-
rons is carried out by SVCT2, the sodium and AA co-transporter
(Daruwala et al., 1999; Castro et al., 2001; Hediger, 2002;
Harrison and May, 2009; Nualart et al., 2012). This protein is
formed by 12 transmembrane domains, with a molecular mass
of ∼75 KDa (García et al., 2005). In the CNS, SVCT2 is expressed
primarily in neurons of the cerebral cortex, hippocampus, and
hypothalamus (Tsukaguchi et al., 1999; García et al., 2005); its
expression has also been described in microglia (Mun et al., 2006)
and tanycytes of the hypothalamus (García et al., 2005). In addi-
tion, functional SVCT2 was observed in cultures of embryonic rat
cortical neurons (Castro et al., 2001; Astuya et al., 2005). Recently,
SVCT2 mRNA expression was detected in radial glial cells of the
fetal rat brain (Caprile et al., 2009). Moreover, SVCT2 knockout
mice die at birth due to respiratory defects and cerebral hem-
orrhaging; low levels of AA in various tissues were also noted
in SVCT2-null mice (Sotiriou et al., 2002). These data suggest
that SVCT2 and vitamin C are important for normal nervous
system development and neuronal maturation. The neurogenic
niche stem cells are in contact with the CSF, which has high a
concentration of vitamin C. Therefore, vitamin C may be a factor
involved in stem cell differentiation; however, studies regarding
the expression and distribution of the vitamin C transporter,
SVCT2, in neural stem cells of the postnatal brain neurogenic
niche and the effect of vitamin C on neuronal differentiation of
stem cells from the periventricular areas of the brain have not
been performed.
In this study, the expression of SVCT2 at the initial stages of
differentiation of the ventricular neurogenic niche was analyzed
in the rat brain. In addition, the distribution of SVCT2 in the
human ventricular wall at 1 month postnatal development was
assessed. Using P19 cells (an in vitro progenitor cell line with
active proliferation) and primary neurospheres isolated from rat
brain, SVCT2 expression and the effects of vitamin C on neural
differentiation were determined.
MATERIALS ANDMETHODS
ANIMALS
Adult Sprague–Dawley rats and animals at 15–21 days postna-
tal development were used throughout the experiments. Animals
were maintained in a 12 h light/dark cycle with food and water
ad libitum. The handling of the animals was performed in agree-
ment with the “Manual de Normas de Bioseguridad” (Comición
Nacional de Ciencia y Tecnología, CONICYT), and the pro-
cedures were described in the publication entitled, “Guide for
Care and Use of Laboratory Animals” (National Academy of
Science, 2011; http://grants.nih.gov/grants/olaw/Guide-for-the-
care-and-use-of-laboratory-animals.pdf). One month postnatal
human brain tissue samples were obtained from archived samples
previously fixed in 4% paraformaldehyde from the Department
of Pathological Anatomy at Concepcion University. The sam-
ples were obtained in accordance with the accepted standards of
the ethics committee on the use of human specimens and after
informed consent was obtained from all patients.
IMMUNOHISTOCHEMISTRY AND CONFOCAL MICROSCOPY
Rat brain tissue samples were fixed in formalin at 10% v/v
or in Bouin solution and embedded in paraffin after which
7-μm saggital sections were obtained. For the immunohisto-
chemical analysis, the deparaffinized samples were incubated
for 15min in absolute methanol with 3% v/v H2O2. The sec-
tions were incubated with the following primary antibodies
diluted in Tris-phosphate buffer and 1% bovine serum albumin:
anti-PCNA (1:100 DAKO, Carpinteria, CA, USA); anti-Nestin
(1:25 Amersham Pharmacia Bitech., Pittsburgh, PA, USA); anti-
βIII-tubulin (1:500, Promega, Madison, WI, USA); anti-GFAP
(1:200, DAKO); anti-PSA-NCAM (1:25 Hybridoma Bank, Iowa.
IA, USA); anti-S100A (1-200, DAKO); and anti-SVCT2 (G19;
1:50, Santa Cruz Biotechnology, Sta. Cruz, CA, USA). The sam-
ples were then incubated with the appropriate secondary anti-
body conjugated to horse radish peroxidase (HRP), including
HRP-conjugated goat anti-IgG, HRP-conjugated rat anti-IgG,
and HRP-conjugated rabbit anti-IgG (ImmunoPure; PIERCE
Biotechnology, Rockford, IL, USA). The enzymatic activity of
the peroxidase was revealed with diaminobenzidine and H2O2.
To perform inmunofluorescence analysis, secondary antibodies
conjugated to different fluorophores, including Cy2-conjugated
goat anti-IgG, Cy2- or Cy3-conjugated rat anti-IgG; and Cy3-
or Cy5-conjugated rabbit anti-IgG (Jackson Immuno Research,
Pennsylvania, USA), were used. The images (512 × 512 × 8 bits
or 1024 × 1024 × 8 bits) were obtained using a confocal micro-
scope.
In situ HYBRIDIZATION
A PCR product of 620 bp, which was obtained from pcDNA3-
hSVCT2 that was subcloned into pCR-4-Blunt-TOPO (Clontech,
Palo Alto, CA, USA), was used to generate sense and anti-
sense digoxigenin-labeled riboprobes. RNA probes were labeled
with digoxigenin-UTP by in vitro transcription with SP6 or
T7 RNA polymerase following the manufacturer’s instruc-
tions (Boehringer Mannheim, Mannheim, Germany). In situ
hybridization was performed on brain sections mounted on
poly-L-lysine-coated glass slides. The sections were baked at
60◦C for 1 h, deparaffinized in xylene, and rehydrated in graded
ethanol. Following proteinase K treatment (5min at 37◦C in PBS,
1mg/ml), the tissue sections were fixed with 4% paraformalde-
hyde at 4◦C for 5min, washed in cold PBS, and then acety-
lated with 0.1M triethanolamine-HCl (pH 8.0) and 0.25%
acetic anhydride at room temperature for 10min. After a brief
wash, the sections were incubated in pre-hybridization solution
(Boehringer Mannheim) at 37◦C for 30min, and then 25μl of
hybridization mix [50% formamide, 0.6M NaCl, 10mM Tris-
HCl (pH 7.5), 1mM ethylenediaminetetraacetic acid (EDTA),
1 × Denhart’s solution, 10% polyethylene glycol 8000, 10mM
DL-dithiothreitol (DTT), 500mg yeast tRNA/ml, 50mg/ml hep-
arin, 5.0mg/ml DNA carrier, and 1:20–1:100 dilutions of ribo-
probe) were added to each slide. The slides were covered with
glass coverslips and placed in a humidified chamber at 42◦C
overnight. The slides were washed at 37◦C for 30min each in
2 × SSC, 1 × SSC, and 0.3 × SSC. Visualization of digoxi-
genin was performed by incubation with a monoclonal antibody
coupled to alkaline phosphatase (anti-digoxigenin alkaline phos-
phatase Fab fragments diluted 1:500; Boehringer Mannheim) at
room temperature for 2 h. Nitroblue tetrazolium chloride and
5-bromo-4-chloro-3-indolyl-phosphate (Boehringer Mannheim)
were used as substrates for the alkaline phosphatase. Controls
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included use of the sense riboprobe and omission of the
probe.
In vivo BrdU LABELING
Five intraperitonial injections of BrdU at a concentration of
40mg/kg were administered to animals at 19 days postnatal devel-
opment. Samples were obtained at 21 days postnatal development
and fixed in Bouin, and the sections were obtained as previ-
ously described. Briefly, after denaturation of the DNA with 2N
HCl for 30min at 37◦C, the sections were incubated with 5%
BSA for 30min and anti-BrdU (1:1000, Amersham Pharmacia
Biotech) overnight. Detection was made by incubation with rat
peroxidase-labeled anti-IgG or rat Cy3-labeled anti-IgG.
CELL CULTURE
The embryo-derived teratocarcinoma cell line, P19 (McBurney,
1993), was cultured inMinimumEssential MediumEagle (MEM)
(Gibco BRL, Grand Island, NY, USA) supplemented with 5%
fetal bovine serum (FBS), penicillin, and streptomycin. The neu-
rospheres were generated in pretri dishes (10 cm in diameter)
seeded with 1 × 106 cells maintained in culture for 4 days in (1)
MEM (control), (2) MEM supplemented with 200 or 400μMAA
or (3) cultured in neurobasal-B27 (Gibco-BRL).
For neurosphere preparation, adult Sprague–Dawley rats were
sacrificed by cervical dislocation (n = 6 per preparation), and
their brains were removed. The lateral walls of the lateral ven-
tricle were dissected and collected in DMEM-F12 (GIBCO). The
cells were dissociated using a Pasteur pipette in NeuroCult NS-A
(Stem Cells Technologies Inc), and cells were collected by cen-
trifugation at 100× g for 5min. The cell pellets were resuspended
in NeuroCult NS-A, supplemented with 20 ng/ml EGF, 10 ng/ml
bFGF, 2μg/ml heparine and proliferation supplement (StemCells
Technologies Inc). The cells were cultured at 40,000 cells per cm2
on uncoated dishes in the same medium. To analyze the effects of
vitamin C, neurospheres were cultured for 7 days and were treated
with 200 or 400μM AA the last 4 days. The same concentration
of vitamin C was added to the cultured cells each day.
REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION
Total RNA was isolated using Trizol (Invitrogen, Rockville, MD,
USA). For RT-PCR, 1μg of RNA was incubated in 10μl reac-
tion volume containing 10mM Tris-HCl (pH 8.3), 50mM KCl,
5mM MgCl2, 20U RNase inhibitor, 1mM dNTPs, 2.5μM of
oligo d(T) primers, and 50 units of MuLV reverse transcriptase
(New England Biolabs, Ipswich, MA, USA) for 10min at 23◦C
followed by 30min at 42◦C and 5min at 94◦C. Parallel reac-
tions were performed in the absence of reverse transcriptase to
control for the presence of contaminant DNA. For amplifica-
tion, a cDNA aliquot in a volume of 12.5μl containing 20mM
Tris-HCl (pH 8.4), 50mM KCl, 1.6mM MgCl2, 0.4mM dNTPs,
0.04 units of Taq DNA polymerase (Gibco-BRL) and 0.4mM
primers was incubated at 95◦C for 5min, 95◦C for 30 s, 50◦C
for 30 s, and 72◦C for 30 s for 35 cycles with a final extension
at 72◦C for 7min. PCR products were separated by 1.2–1.5%
agarose gel electrophoresis and visualized by staining with ethid-
ium bromide. The following set of primers was used to analyze
the expression of SVCT2: sense: 5′TGTTTCAGGCCAGTGCTTT
3′ and antisense: 5′GAAAGGATGGACGGCATACA 3′ (expected
product of 457 bp). Additionally, the following sets of primers
were used to analyze the expression of nestin and βIII-tubulin:
nestin sense, 5′GGAGTCTCGCTTAGAGGTGC 3′ and antisense,
5′ CAGCAGAGTCCTGTATGTAGCC 3′ (expected product 103
bp) and βIII-tubulin sense, 5′ TTTATCTTCGGTCAGAGTGG
3′ and antisense, 5′ GAGCAGCAGTAGAAGTATGT 3′ (expected
product 1500 bp).
WESTERN BLOT ANALYSIS
Membrane proteins from P19 cells or neurospheres were obtained
by homogenizing the cells in 0.3mM sucrose, 3mM DTT, 1mM
EDTA, 1.0mg/ml PMSF, 1mg/ml pepstatin A, 2mg/ml leupeptin,
and 2mg/ml aprotinin. Total membranes were collected by high-
speed centrifugation. For immunoblotting, 50mg of membrane
protein was loaded in each lane and separated by polyacry-
lamide gel electrophoresis in the presence of sodium dodecyl sul-
fate, transferred to PVDF membranes (0.45μm pore, Amersham
Pharmacia Biotech., Piscataway, NJ, USA) and probed against
an anti-SVCT2 (1:100) antibody or a preabsorbed antibody
(1:500) (García et al., 2005). The secondary antibody was rabbit
anti-goat IgG coupled to peroxidase (1:5000). The reaction was
developed with enhanced chemiluminescence according to the
manufacturer’s instructions (Amersham Corporation, Arlington
Heights, IL).
VITAMIN C UPTAKE STUDIES
P19 cells were carefully selected under the microscope to
ensure that only plates showing uniformly growing cells
were used at 200,000 cells/well. Additionally, neurospheres
isolated from rat brain were also used for vitamin C
uptake. The cells were incubated in buffer containing 15mM
HEPES (N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid),
135mM NaCl, 5mM KCl, 1.8mM CaCl2, 0.8mM MgCl2 at
room temperature for 30min. Uptake assays were performed
in 500ml of incubation buffer containing 0.1–0.4mCi of 1-
14C-AA (Dupont NEN, Boston, MA, USA, specific activity
8.2mCi/mmol) to a final concentration of 100mM. Data repre-
sent means ± SD of three experiments with each analysis per-
formed in duplicate. To analyze the effect of AA on SVCT2 expres-
sion and function, P19 cells were pre-incubated with 400mM AA
for 4 days. Initial velocity transport assays were performed after
incubation with 100mM AA with or without 135μM sodium
chloride (replaced by sodium choline) or 20μM cytochalasin B.
STATISTICAL ANALYSIS
For inhibition experiments, statistical comparisons between two
or more groups of data were carried out using analysis of vari-
ance (ANOVA, followed by Bonferroni post-test). P < 0.05 was
considered to be statistically significant. The statistical software,
GraphPad Instat 3.0 (GraphPad Software, Inc., La Jolla, CA 92037
USA), was used for data analysis.
RESULTS
POSTNATAL NEUROGENIC NICHE DIFFERENTIATION
The ventricular neurogenic niche of postnatal brains at 15 days
showed a similar cellular structure to that described in the adult
Frontiers in Cellular Neuroscience www.frontiersin.org August 2013 | Volume 7 | Article 119 | 3
Pastor et al. SVCT2 in brain progenitor cells
brain (Doetsch et al., 1997; Alvarez-Buylla and Garcia-Verdugo,
2002; Alvarez-Buylla and Lim, 2004). The ependymal cells were
differentiated in the ventricular wall, and the SVZ was formed
by different cell types (Figure 1). The migration of cells to the
olfactory bulb, the RMS, was also assessed (Figures 1A, insets
1–2 and B). At 15 days, a positive reaction with anti-PCNA in
the SVZ was observed (Figures 1A, inset 1, C,G); the ependymal
cells were also labeled with anti-S100A (Figures 1D,H). Type-B
precursor cells (GFAP-positive) were also detected in the SVZ
(Figures 1E,I). βIII-tubulin expression was observed in neurob-
lasts (Figures 1F,J,K, arrows) surrounded by B-type cells reactive
to GFAP (Figures 1L,M). GFAP-positive cells presented radial
morphology, and their processes extended to the subventricular
region (Figures 1L,M).
Mitotically active cells were next detected by in vivo BrdU
administration. All the BrdU-positive cells were observed
in the subventricular region (Figure 1N), a result that was
confirmed by analysis with anti-S100, an ependymal cell
marker (Figures 1O,P). Approximately, ten percentage of the
BrdU-positive cells were also GFAP-positive (Figures 1Q–S).
BrdU-positive cells were also detected at the RMS
(Figure 1 N,Q).
EXPRESSION OF SVCT2 IN THE NEUROGENIC NICHE AND RMS
Using in situ hybridization, SVCT2 mRNA expression was
observed in the anterior ventricular zone and RMS (Figure 2A).
SVCT2 mRNA expression was also located in other areas of the
brain, including neurons of the hippocampus (Figure 2B), cere-
bral cortex (Figure 2D), and the cerebellum (Figure 2E). As a
negative control, the sense probe was employed; no reaction was
observed in the different cerebral areas analyzed (Figure 2C).
Furthermore, a positive reaction to astrocytes was not observed;
however, ependymal cells presented an intense reaction in differ-
ent regions of the ventricular wall (data not shown).
García et al. (2005) had demonstrated that SVCT2 mRNA
expression did not directly correlate with its protein levels.
Specifically, neurons presenting an intense in situ hybridization
signal for SVCT2 showed a weak immunoreactivity with anti-
SVCT2. Thus, SVCT2 protein expression was determined using
immunofluorescence and confocal microscopy in the neurogenic
niche, and intense immunoreactivity in the anterior ventricular
area and RMS was detected (Figure 3A, insets). The positive sig-
nal was observed in the ependymal cells and different cells present
in the SVZ (Figure 3A, inset and arrows). To determine whether
SVCT2 was associated with proliferative cells, co-localization
FIGURE 1 | Characterization of the neurogenic niche at 15 days postnatal
development. (A) Scheme of a sagittal section of rat brain, highlighting the
anterior ventricular zone, the neurogenic niche of the subventricular zone
(SVZ), and the rostral migratory stream (RMS). Insets 1 and 2:
Immunohistochemical analysis with anti-PCNA (1:100) in the SVZ and the
RMS, respectively. (B) Sagittal cut of rat brain stained with hematoxylin and
eosin showing the RMS (arrows). (C–J) Neurogenic niche of the brain at 15
days postnatal development analyzed with anti-PCNA, anti-S100a, anti-GFAP,
and βIII-tubulin. (K–S) Immunofluorescence and confocal microscopy
analyses using antibodies to identify glial and neural cells in different states of
proliferation. (K–M) Brain tissue analyzed with anti-βIII-tubulin and GFAP.
(N–P) Co-localization of S100a-positive ependymal cells and BrdU-positive
cells. (Q–S) Co-localization of GFAP-positive glial cells and BrdU-positive cells.
The images are representative of three independent experiments. CP, choroid
plexus; LV, lateral ventricle; OB, olfactory bulb. Scale bars in (B), 250μm;
(C–J), 100μm; (K–S), 50μm.
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FIGURE 2 | Expression of SVCT2 mRNA in the neurogenic niche and
RMS. in situ hybridization analysis of a sagittal section of rat brain at 21
days postnatal development. (A) A positive reaction was observed in the
anterior wall of the lateral ventricle as well as in the ventricular and
subventricular zones. A positive reaction was also observed in the RMS
(arrows). (B,D,E) Positive in situ hybridization in different regions of the
CNS: hippocampus (B), cerebral cortex (D), cerebellum (E). (C) Negative
control using the sense probe. LV, lateral ventricle; SVZ, subventricular
zone; RMS, rostral migratory stream. Scale bar, 100μm.
analysis was undertaken with BrdU-positive cells (Figure 3B,
insets). Most of the BrdU-positive cells were also SVCT2-positive
(Figure 3C, insets), and a high percentage of these cells were local-
ized in the SVZ (Figures 3C, insets and D–F). The number of
BrdU/SVCT2-positive cells was next quantified in two rat brains;
of 494 BrdU-positive cells in the neurogenic niche, 95.1% were
also SVCT2-positive.
To determine the cell types within the neurogenic niche that
express SVCT2, immunofluorescence analysis with triple labeling
was undertaken (Figure 4). At 21-days postnatal development,
SVCT2 did not co-localize with βIII-tubulin (Figure 4A) or with
GFAP (Figure 5B). High power imaging in different regions of the
neurogenic niche and in the RMS confirmed these observations
(Figures 4C–N). SVCT2 reactions were observed in ependymal
cells and cells located in the SVZ, again without co-localizing
with GFAP (Figures 4D,H) and with low co-localization with
βIII-tubulin (Figures 4E,I). A similar result was found in the
RMS (Figures 4K–N), suggesting that SVCT2 is present in highly
proliferative intermediate progenitors (C type cell or nIPC).
Analysis of the ventricular wall of a human brain at 1
month postnatal development was next performed. The presence
FIGURE 3 | Mitotically active cells express SVCT2. Immunofluorescence
and confocal microscopy analyses of the neurogenic niche and RMS at 21
days postnatal development, using antibodies to identify proliferative cells
and the ascorbic acid transporter, SVCT2. (A) Sagittal section of the rat
brain analyzed with anti-SVCT2. (B) Sagittal section of rat brain analyzed
with anti-BrdU, 5 days after incorporation of BrdU in vivo. (C–F)
Co-localization of SVCT2- and BrdU-positive cells in the neurogenic and
RMS areas. The images are representative of three independent
experiments. LV, Lateral ventricle; RMS, rostral migratory stream. Scale
bars in (A–C), 100μm. Arrows point positive cells for SVCT2 and BrdU.
of βIII-tubulin-positive neuroblasts in the SVZ was observed
(Figure 5). These cells had varying morphologies; some were
spherical and closely located to ependymal cells while others
were more elongated and positioned tangentially to the ependy-
mal layer (Figures 5A–C, arrows). Analysis of GFAP identified
the subventricular astrocyte band that was located immediately
below the ependymal cells (Figure 5D). Some cells had pro-
cesses inserted among the ependymal cells, directly contacting
the CSF (Figures 5E,F, inset and arrows). SVCT2 expression was
identified in the ependymal cells and in the SVZ. Whereas the
immunoreaction of the ependymal cells was intense throughout
the whole cell, the reaction to SVCT2 was concentrated in specific
areas of the cells in the SVZ (Figures 5G,J). The signal for SVCT2
rarely co-localized with GFAP-positive or βIII-tubulin-positive
cells (Figures 5I,L).
VITAMIN C INCREASES SVCT2 AND βIII-TUBULIN EXPRESSION
Because various factors can enhance neural differentiation (Dhara
and Stice, 2008), the effect of vitamin C on neural differentia-
tion was determined using P19 cells. P19 cells form neurospheres
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FIGURE 4 | Distribution of SVCT2, GFAP, and βIII-tubulin in the cells of
the ventricular area and the RMS. Immunofluorescence and confocal
microscopy analyses of the ventricular neurogenic niche after 21 days
postnatal development using antibodies to identify glial cells, neurons and
SVCT2. (A) Sagittal section of rat brain analyzed with anti-SVCT2 and
anti-βIII-tubulin. (B) Sagittal section of rat brain analyzed with anti-SVCT2 and
anti-GFAP. (C–P) Co-localization of glial and neural cells with anti-SVCT2
(green), anti-GFAP (blue), and anti-βIII-tubulin in the dorsal (C–F) and ventral
neurogenic niche (G–J). (K–N) Co-localization of glial and neural cells in the
RMS. The images are representative of three independent experiments. Ep,
ependymal cells. LV, lateral ventricle. Scale bars in (A–B), 100μm;
(C–N), 20μm.
in vitro, which are immunoreactive to nestin, SVCT2 and βIII-
tubulin (Figures 6A–C). The expression of these markers was also
confirmed using RT-PCR (Figure 6D) and Western blot analy-
ses (Figure 6E). Moreover, functional studies revealed that AA is
incorporated at a velocity of 100 pmoles × 106 cells/min in the
P19 cells, an uptake that remained constant for up to two min of
transport (Figure 6F). In the absence of sodium, AA uptake was
inhibited by 70% (Figure 6G). To confirm that AA is not being
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FIGURE 5 | Detection of cells reactive to GFAP, βIII-tubulin, and SVCT2 in
the ventricular wall of the postnatal human brain. (A–F)
Immunohistochemical analysis using antibodies to identify glial and neural
cells. (A–C) Sagittal section of the ventricular wall of the human brain at 1
month postnatal development analyzed with antibodies specific for βIII-tubulin
(A–C) or anti-GFAP (D–F). (G–L) Immunofluorescence and confocal
microscopy analyses of the human ventricular neurogenic niche, using
antibodies to identify glial and neural cells and the SVCT2. Sagittal section of
the ventricular wall analyzed with anti-GFAP and anti-SVCT2 (G–I) or
anti-βIII-tubulin and anti-SVCT2 (J–L). The images are representative of three
independent experiments. Ep, ependymal cells; LV, lateral ventricle. Scale bars
in (A–K), 20μm. Arrows point positive cells for the respective antibodies.
transported by GLUTs, AA transport was determined in the pres-
ence of cytochalasin B, an inhibitor of GLUT transporters that
incorporates DHA. The presence of this molecule did not inhibit
AA transport (Figure 6G). Consequently, these results indicate
that P19 cells express functional SVCT2.
To evaluate the effect of vitamin C on neurosphere for-
mation by P19 cells, the culture were maintained with MEM
(Figure 6H,K,O) or supplemented with 200 or 400μM AA for
four days (Figures 6I,L,P). As a positive control, the neuro-
spheres were cultured in neurobasal/B27 medium to stimulate
neural differentiation (Figures 6J,M,N,Q). After culture in MEM
alone, the neurospheres had a lower number of βIII-tubulin-
positive cells, even when the majority of the cells in the neu-
rosphere were slightly positive for SVCT2 (Figure 6K). After
treating the neurospheres with 400μMAA vitamin C, an increase
in neural differentiation was detected as observed by the pres-
ence of intensely βIII-tubulin-positive cells (Figure 6I). These
cells were also highly immunoreactive to SVCT2 (Figures 6L,P).
A similar response was observed with neurospheres cultured with
neurobasal/B27 medium (Figures 6J,M,Q). Western blot analysis
confirmed that AA as well as neurobasal/B27 medium increased
the levels of βIII-tubulin by two-fold (Figures 6R,S). Finally, AA-
treated P19 cells increased AA incorporation by approximately
six-fold as compared to the control (Figure 6T).
Similar results were observed using primary neurospheres iso-
lated from the lateral wall of the lateral ventricle of adult rats
supplemented with 200μM AA or 400μM (data not shown) for
four days. After 7 days in vitro (Figure 7A), the neurospheres cells
showed positive immunostaining for anti-GFAP and anti-nestin
(Figures 7B,C); however, low immunoreaction was observed with
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FIGURE 6 | Expression and function of SVCT2 in P19 cells. (A–C)
Culture of P19 cells for 4 days in vitro in MEM medium. The expression of
nestin (A), SVCT2 (B), and βIII-tubulin (C) was analyzed in the resultant
neurospheres. (D) RT-PCR analysis using specific primers for βIII-tubulin,
nestin, and SVCT2. (E) 3 Western blot analysis using antibodies that
recognize βIII-tubulin, nestin, and SVCT2. (F) Functional analysis of the
uptake of 100μM AA over 7min. (G) Uptake of 100μM AA in the
presence/absence of sodium ions or cytochalasin (B). (H–Q) Analysis with
anti-SVCT2 and anti-βIII-tubulin antibodies in P19 cell cultures at 4 days
in vitro using different culture conditions. Topro was used to identify the
nucleus of the cells (blue). (H,K,O) Cells cultured in MEM medium. (I,L,P)
Cells cultured in MEM medium supplemented with 400μM vitamin C.
(J,M,Q) Cells cultured in neurobasal/B27. (R) Western blot analysis for
βIII-tubulin in P19 cells cultured in the presence of AA or Neurobasal/B27.
(S) Quantitative analysis of the Western blot analysis. (T) Uptake of
100μM AA in P19 cells cultured in MEM supplemented with 400μM of
vitamin C for 4 days in vitro. The data represent the average and standard
deviation of three experiments analyzed by One-Way ANOVA with the
Bonferroni post-test. ∗p < 0.05, ∗∗∗p < 0.005. Scale bars in (A–C), 50μm,
(H–Q), 30μm.
anti-βIII-tubulin (Figure 7D). In addition, uptake of AA was
inhibited by choline and quercetin (Figure 7E). When the cells
were treated with AA, decreased anti-GFAP immunoreaction
was observed (Figures 7F,G); however, the reaction for βIII-
tubulin increased (Figures 7H,I,L,M). Additionally, an increased
immunoreaction for SVCT2 was observed by immunohistochem-
istry and Western blot analyses (Figures 7J,K,L,N).
DISCUSSION
Different studies suggest that intracellular vitamin C may regu-
late the activation of diverse protein kinases, and thereby regulate
transcription factor activity and the expression of pro-neural
genes (Bowie and O’Neill, 2000; Carcamo et al., 2002; Park et al.,
2005; Frebel and Wiese, 2006; Mimori et al., 2007). Vitamin
C also helps to maintain iPS cells in vitro, which favored their
proliferation (Esteban et al., 2010). Neural tissue has been shown
to attain AA concentrations that rank among the highest of
mammalian tissues (Horning et al., 1975; Kratzing et al., 1982;
Milby et al., 1982). In fact, vitamin C levels are particularly
high in fetal rat brain, doubling from the 15th to the 20th day
of gestation.
To determine the postnatal period during which the neuro-
genic niche is formed, a detailed immunochemical characteriza-
tion of the first 3 weeks of postnatal development was conducted.
Cellular distribution during this period was compared to the
cellular distribution of the neurogenic niche and the RMS of
the adult brain. Ependymal differentiation was observed begin-
ning at day 7 postnatal development (data not shown), which
was similar previous studies (Silva-Alvarez et al., 2005; Spassky
et al., 2005). Between days 7 and 21 of development, an intense
immunoreactivity to GLUT1 (Silva-Alvarez et al., 2005) and the
S100 protein was observed (Figure 8A). However, the radial glia
was not present (Hartfuss et al., 2001). Thus, the first cell in
the neurogenic niche to differentiate itself was the ependymal
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FIGURE 7 | Vitamin C treatment increases neural differentiation in
neurospheres. In vitro culture of neurospheres at 7 days using different
culture conditions, and analysis with anti-GFAP, anti-nestin, anti-SVCT2 and
anti-βIII-tubulin. Topro was used to identify the nucleus of the cells (blue). (A–D)
Neurospheres cultured in NeuroCult NS-A medium showed immunoreaction
for anti-GFAP and anti-nestin. Low immunoreaction for anti-βIII-tubulin was
observed. (E) Uptake of 100μM AA (10min) and effect of choline and
quercetin in cultured neurospheres. (F–K) Neurospheres cultured in NeuroCult
NS-A medium supplemented with 200μM vitamin C (G,I,K) or control
neurospheres without supplementation (F,H,J). Increased βIII-tubulin-positive
cells were detected in AA-supplemented neurospheres (I). (L) Western blot
analysis for βIII-tubulin and SVCT2 expression in neurospheres cultured in the
presence of AA or control medium. (M,N) Quantitative analysis of the
Western blot. The data represent the average and standard deviation of three
experiments analyzed by One-Way ANOVA with the Bonferroni post-test.
∗p < 0.05, ∗∗∗p < 0.005. Scale bars in (A–D), 120μm; (F–K), 50μm.
cell. Ependymal differentiation could be directly related to the
subsequent formation of the neurogenic niche. Noggin secretion
by the ependyma stimulates the neurogenic process, acting as an
antagonist of bone morphogenic proteins 2 and 4 (BMP2 and
BMP4, respectively), factors that stimulate gliogenesis (Lim et al.,
2000; Sabo et al., 2009).
GFAP-positive cells were only identified in the SVZ at day
15, indicating the presence of type-B precursor cells (Doetsch
et al., 1999; Sanai et al., 2011). The distribution of these cells
was similar to what has been described previously for the adult
brain (Doetsch et al., 1999; Ma et al., 2005, 2009; Nualart
et al., 2012). In addition to the type-B cells, neuroblasts that
form the RMS were also identified. Furthermore, the RMS was
composed preferentially of cells from the neural lineage reactive
to βIII-tubulin and GFAP (Alvarez-Buylla and Lim, 2004; Merkle
et al., 2007). The formation of the RMS is additional evidence
for concluding that the neurogenic niche forms at day 15. Using
in vivo BrdU labeling, proliferative type-B cells increased notably
at day 21 (Doetsch and Alvarez-Buylla, 1996; Doetsch et al., 1997;
Kee et al., 2002) and were in close contact with the ependy-
mal layer. These cells had a long process that contacted the
blood vessels forming a specialized vascular niche (Voigt, 1989;
Leprince and Chanas-Sacre, 2001; Alvarez-Buylla and Garcia-
Verdugo, 2002; Noctor et al., 2002; Mirzadeh et al., 2008; Shen
et al., 2008; Tavazoie et al., 2008). Therefore, factors arising
from the CSF and blood vessels could regulate the differentiation
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FIGURE 8 | Cytoarchitecture of the human and rat neurogenic niche
and SVCT2 expression. Rat (A) and human neurogenic niche (B), showing
type-B GFAP-positive cells (blue cells) in the ependymal, contacting the CSF
(grey cells) and subventricular neuroblasts (red cells). SVCT2 is expressed
principally in the ependyma and in GFAP-negative and βIII-tubulin-negative
type C subventricular progenitor cells (green cell). OB, olfactory bulb; CSF,
cerebrospinal fluid; RMS, rostral migratory stream; VZ, ventricular zone;
SVZ, subventricular zone.
of the neurogenic niche (Shen et al., 2004; Mirzadeh et al.,
2008).
Previous studies have observed SVCT2 expression in cerebral
cortex, hypothalamus, hippocampus, thalamus and cerebellar
neurons (Tsukaguchi et al., 1999; Castro et al., 2001; Astuya et al.,
2005; García et al., 2005; Caprile et al., 2009; Nualart et al., 2012).
This transporter is fundamental for the neural development of
CNS, which was confirmed with the use of SVCT2 knock-out ani-
mals (Sotiriou et al., 2002). Qiu et al. (2007) demonstrated that
neural cultures from SVCT2 knock-out animals had lower rates
of neurite growth and reduced neural activity (Qiu et al., 2007).
SVCT2 expression was also reported in hypothalamic tanycytes,
ependymal cells, marginal astrocytes and microglia (García et al.,
2005; Mun et al., 2006; Nualart et al., 2012).
Vitamin C may induce neural and glial differentiation in
embryonic cortical precursors and mesencephalic precursor cells
(Lee et al., 2000, 2003; Yan et al., 2001). AA concentrations in
the CSF may reach up to 500 and 200–400μM in regions of the
cerebral parenchyma (Spector and Lorenzo, 1974). The presence
of the vitamin C transporter, SVCT2, in the ventricular neuro-
genic area after 15 days postnatal development was analyzed in
the present study. The expression of SVCT2 in ventricular and
subventricular areas has only been described in the embryonic rat
brain (Caprile et al., 2009). However, the expression of SVCT2
in postnatal neurogenic areas remains unknown. Using immuno-
histochemical analysis, the present study was the first to identify
SVCT2 expression in postnatal rat brain and in the human neu-
rogenic niche at 1 month postnatal development (Figures 8A,B).
These results were confirmed by in situ hybridization, observing
positive hybridization in the SVZ and RMS. Double and triple-
labeling techniques revealed low co-localization of SVCT2 (rat
and human) with GFAP and βIII-tubulin, indicating that type-
B cells and neuroblasts would have a low capacity to transport
vitamin C. Alternatively, co-localization of SVCT2 with BrdU-
positive cells, in particular in the SVZ, suggests that type-C cells
with high mitotic activity (Doetsch et al., 1999; Alvarez-Buylla
and Garcia-Verdugo, 2002; Kriegstein and Alvarez-Buylla, 2009)
preferentially express this transporter. SVCT2 also co-localized
with BrdU in the RMS, suggesting the presence of progenitors or
similar cells (Doetsch and Alvarez-Buylla, 1996).
The transport of vitamin C to type-C cells of the SVZ can
be explained by diffusion from the CSF as vitamin C is present
at concentrations up to 10-fold higher than that observed in
blood (Tsukaguchi et al., 1999; García et al., 2005). Finally, as
observed in the present study, SVCT2 was widely expressed in the
postnatal neurogenic area and RMS, suggesting that mitotically
active type-C progenitors preferentially express the transporter.
Unfortunately, it was not possible to co-localize SVCT2 with
markers of type C cells due to technical problems associated with
the use of picric acid within the Bouin solution that was used as a
fixative for identifying SVCT2.
Precursor cells have the ability to form neurospheres (Reynolds
and Weiss, 1992, 1996; Doetsch et al., 1999; Nunes et al., 2003;
Chojnacki et al., 2009). In this work, primary neurospheres from
rat brain and P19-derived neurospheres expressed nestin, GFAP
and βIII-tubulin, and functional SVCT2. Supplementation of 4
days in vitro P19-derived neurospheres with 400μM vitamin C
increased their expression of βIII-tubulin, which has also been
observed in embryonic precursor cells (Yan et al., 2001). In addi-
tion, a six-fold increase in the incorporation of AA was observed
in P19 cells cultured with vitamin C, which was similar to the
results obtained after culturing cells in Neurobasal/B27 medium,
a condition that induces neural differentiation (Hemmati et al.,
2003; Beier et al., 2007). Finally, we used primary neurospheres
isolated from rat brain to define the effect of 200 or 400μM
vitamin C; 200μM vitamin C produced a similar differentiation
effect to that observed in P19 cells treated with 400μM vita-
min C. The differential response to vitamin C concentration may
be due to the level of SVCT2 expression and/or its functional
activity in the cells. Because vitamin C uptake by cells is depen-
dent on the affinity of the transporter as well as its concentration
in the cellular membrane, we think that the functional activity
of SVCT2 is increased in neurospheres. Additionally, increased
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SVCT2 expression was observed in primary neurospheres after
AA treatment. In conclusion, we suggest that vitamin C and
SVCT2 may be important in inducing neurogenesis in postnatal
stages.
The specific mechanisms through which vitamin C and SVCT2
induce neural differentiation remain unknown although some
evidence suggests the involvement of gene expression related
to neurogenesis and maturation (Lee et al., 2003; Shin et al.,
2004; Yu et al., 2004). SVCT2 may be regulated in differentiation
through its phosphorylation sites dependent on protein kinase C
(PKC) and protein kinase A (PKA) (Daruwala et al., 1999; Rajan
et al., 1999; Tsukaguchi et al., 1999; Wang et al., 1999, 2000)
since its phosphorylation is essential for translocation to the cel-
lular membrane and subsequent AA uptake (Wu et al., 2007).
The level of SVCT2 in the cellular membrane is also increased
by prostaglandin E through the activation of the EP4 and PK
prostaglandin receptor (Wu et al., 2007).
In this study, differentiation of the postnatal neurogenic
niche at days 15 and 21 was analyzed by determining the
expression pattern of the AA transporter, SVCT2 (Figure 8).
SVCT2 was expressed in the highly proliferative cells of the
neurogenic niche. Additionally, primary neurospheres prepared
from rat brain and the P19 teratocarcinoma cell lines also
expressed SVCT2, which is involved in AA uptake. Vitamin C-
induced neural differentiation increased βIII-tubulin and SVCT2
expression.
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